The middle region of tirzepatide in GLP-1R was stabilized by the peptide-ECD-ECL1-ECL2 interface through both a polar network (T298 45.52b -S11 P -Y205 ECL1 -R299 ECL1 -D15 P -L32 ECD -S31 ECD -Q19 P ) and a complementary nonpolar network with ECD (L32, V36, W39 and Y88), ECL1 (W214), TM1 (L141 1.36b ) and TM2 (L201 2.71b ) via S11 P , Aib13 P , F22 P , W25 P and L26 P (Fig
Hormones (2013) 12:1929
When you are on a GLP-1 medication, your body is working to stabilize insulin and glucose levels
GLP-1 forms the basis for a variety of current drugs for the treatment of type 2 diabetes and obesity, as well as new agents currently being developed
Recommendations are individualized based on medical history, current medications, wellness goals, and clinical appropriateness
Oncogene 29 , 313324 (2010)